Efficacy and safety of PDE5-Is and α-1 blockers for treating lower ureteric stones or LUTS: a meta-analysis of RCTs

Table 1 Characteristics of the included studies of lower ureteric stones in meta-analysis

Author	Year	Country	Characteristics of participants		Design	Intervention	No.	Study interval	Comparable index	Jadad score
Author	Year	Country	location	size	Design	Intervention	No.	Study interval	Comparable index	Jadad score
Kumar	2015	India	distal ureteric stones	5-10 mm	RCT	tamsulosin 0.4 mg qd tadalafil 10 mg qd silodosin 8 mg qd	90 90 90	4 weeks	age,gender,stone size,expulsion rate,expultion time,analgesic use,AEs	6
KC	2016	Nepal	distal ureteric stones	5-10 mm	RCT	tamsulosin 0.4 mg qd tadalafil 10 mg qd	41 44	2 weeks	age,gender,stone size, expulsion rate, expulsion time,analgesic use,AEs	4
Puvvada	2016	India	distal ureteric stones	5-10 mm	RCT	tadalafil 10 mg qd tamsulosin 0.4 mg qd	100,100	4 weeks	age, gender, stone size, expulsion rate, expulsion time, analgesic use, AEs	6
Kumar	2014	India	distal ureteric stones	5-10 mm	RCT	tamsulosin 0.4 mg qd + tadalafil 10 mg qd	31	6 weeks	age,gender,stone size, expulsion rate, expulsion time,analgesic use, AEs	4
Kumar	2014	India	distal ureteric stones	5-10 mm	RCT	tamsulosin 0.4 mg qd	31	6 weeks		4
Jayant	2014	India	distal ureteric stones	5-10 mm	RCT	tamsulosin 0.4 mg qd + tadalafil 10 mg qd	122	4 weeks	age, gender,stone size, expulsion rate, expulsion time, analgesic use, AEs	5
Jayant	2014	India	distal ureteric stones	5-10 mm	RCT	tamsulosin 0.4 mg qd	122	4 weeks		5

ISSN: 1471-2490